HEPATITIS A VACCINE
- 1 December 2000
- journal article
- review article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 19 (12) , 1187-1188
- https://doi.org/10.1097/00006454-200012000-00015
Abstract
Inactivated hepatitis A vaccines are highly immunogenic and efficacious. Because of their high disease rates and importance as a reservoir of transmission to others, children should be the primary focus of vaccination. A long-term strategy of sustained routine vaccination of children living in areas with consistently elevated hepatitis A rates has been adopted. Ultimately, elimination of HAV transmission will require vaccination of all children in the US. This effort would be facilitated by the availability of vaccine formulations or schedules for use in infants or children in the second year of life, and combination vaccines that include hepatitis A.Keywords
This publication has 8 references indexed in Scilit:
- Sources of Infection Among Persons With Acute Hepatitis A and No Identified Risk Factors During a Sustained Community-Wide OutbreakPediatrics, 2000
- Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccinesJournal of Medical Virology, 2000
- Concurrent administration of inactivated hepatitis A vaccine with immune globulin in healthy adultsVaccine, 1999
- Immunization of seronegative infants with hepatitis A vaccine (HAVRIX®; SKB): a comparative study of two dosing schedulesVaccine, 1997
- Clinical Experience With An Inactivated Hepatitis A VaccineThe Journal of Infectious Diseases, 1995
- A Controlled Trial of a Formalin-Inactivated Hepatitis A Vaccine in Healthy ChildrenNew England Journal of Medicine, 1992
- FREQUENCY OF ILLNESS ASSOCIATED WITH EPIDEMIC HEPATITIS A VIRUS INFECTIONS IN ADULTSAmerican Journal of Epidemiology, 1985
- Hepatitis A in Day-Care CentersNew England Journal of Medicine, 1980